The CDC will review COVID-19 vaccine safety, as health experts criticize a potential lack of scientific basis for this move.

The ACIP was scheduled to discuss COVID-19 vaccine injuries at a March meeting, potentially voting on future immunization recommendations.

In the critical arena of public health, remaining neutral when confronted with misinformation is detrimental. In the case of ...

Your partner is allowed to choose a very risk-averse life. But you are equally allowed to choose a life that includes social ...

The aged care home at the centre of a deadly Covid outbreak in July 2020 has admitted it failed to ensure all staff were ...

Elia addressed the DECLARATION study for VYD2311: "We were recently notified that the DECLARATION clinical trial has reached target enrollment...may modestly over enroll as sites are permission to ...

Naples City Council hasn't changed its decision not to allow a full concession stand at the Naples Pier, but may allow ...

European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...

The FDA's top drug regulator, Tracy Beth Hoeg, MD, PhD, is working to hire a researcher and friend who wants the agency to ...

Accelerated review was enabled by the Commissioner’s National Priority Voucher Pilot Program, targeting high unmet need and compressing FDA action to 1–2 months with enhanced reviewer communication.

The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who ...

Complimentary Educational Session Scheduled for March 11 As imaging volumes continue to grow, virtual supervision ...